Literature DB >> 26104728

Non-transferrin-bound iron is associated with biomarkers of oxidative stress, inflammation and endothelial dysfunction in type 2 diabetes.

Husam Aljwaid1, Desley L White2, Keith J Collard3, A John Moody4, Jonathan H Pinkney5.   

Abstract

AIMS: To investigate the association between circulating non-transferrin-bound iron [NTBI], and markers of oxidative stress, endothelial function and inflammation in subjects with type 2 diabetes and non-diabetic subjects with varying degrees of obesity.
METHODS: Plasma NTBI was measured by HPLC, together with total iron, iron-binding capacity, transferrin saturation and soluble transferrin receptor, together with total and reduced ascorbate, malondialdehyde [MDA], E-selectin and high-sensitivity c-reactive protein [hs-CRP] in groups of 28 subjects with type 2 diabetes, 28 non-obese controls and 17 obese non-diabetic subjects.
RESULTS: Levels of NTBI were higher than controls in the diabetes group, but the total serum iron levels were lower. MDA levels were higher than controls in both the diabetes and obese groups, and this was associated with higher levels of oxidised ascorbate. hs-CRP levels were higher in both the diabetes and obese groups, and E-selectin was significantly higher in the diabetes group. There were strong positive correlations between HbA1c levels and NTBI [P<0.01], HbA1c and E-selectin [P<0.001] and NTBI and E-selectin [P<0.02] in the diabetes group.
CONCLUSION: These results support the hypothesis that iron-mediated oxidative stress may be a mechanism linking poor glycaemic control with vascular dysfunction in type 2 diabetes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Endothelial dysfunction; Non-transferrin-bound iron; Obesity; Oxidative stress; Type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26104728     DOI: 10.1016/j.jdiacomp.2015.05.017

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  7 in total

1.  Plasma Non-transferrin-Bound Iron Could Enter into Mice Duodenum and Negatively Affect Duodenal Defense Response to Virus and Immune Responses.

Authors:  Xiaonan Yu; Qian Zhang; Haoxuan Ding; Peng Wang; Jie Feng
Journal:  Biol Trace Elem Res       Date:  2022-03-16       Impact factor: 3.738

Review 2.  The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications.

Authors:  Stéphanie Dal; Séverine Sigrist
Journal:  Diseases       Date:  2016-07-11

3.  Analytical evaluation of serum non-transferrin-bound iron and its relationships with oxidative stress and cardiac load in the general population.

Authors:  Tomonori Sugiura; Yasuaki Dohi; Hiroyuki Takase; Satoshi Fujii; Yoshihiro Seo; Nobuyuki Ohte
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

4.  Analysis of oxidative stress, inflammation and endothelial function following intravenous iron in chronic kidney disease in the Iron and Heart Trial.

Authors:  Xenophon Kassianides; Victoria Allgar; Iain C Macdougall; Philip A Kalra; Sunil Bhandari
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

Review 5.  Iron Reshapes the Gut Microbiome and Host Metabolism.

Authors:  Amy Botta; Nicole G Barra; Nhat Hung Lam; Samantha Chow; Kostas Pantopoulos; Jonathan D Schertzer; Gary Sweeney
Journal:  J Lipid Atheroscler       Date:  2021-03-10

Review 6.  Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron.

Authors:  Francesca Vinchi
Journal:  Antioxid Redox Signal       Date:  2021-03-22       Impact factor: 8.401

7.  Serum ferritin as a risk factor for type 2 diabetes mellitus, regulated by liver transferrin receptor 2.

Authors:  Rui Zhang; Xinmei Huang; Yue Li; Zhiyan Yu; Yueyue Wu; Bingbing Zha; Heyuan Ding; Shufei Zang; Jun Liu
Journal:  Endocr Connect       Date:  2021-11-25       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.